Search company, investor...

Stage

Unattributed VC | Alive

Total Raised

$2.2M

Last Raised

$2.2M | 13 yrs ago

About Flexicath

Flexicath develops catheter insertion systems to ensure simple, safe, and sterile intravenous catheterization.

Headquarters Location

Israel

Loading...

Loading...

Flexicath Patents

Flexicath has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/6/2006

12/24/2013

Catheters, Arteries of the abdomen, Cardiac procedures, Interventional radiology

Grant

Application Date

11/6/2006

Grant Date

12/24/2013

Title

Related Topics

Catheters, Arteries of the abdomen, Cardiac procedures, Interventional radiology

Status

Grant

Latest Flexicath News

FDA clears pressure-injectable catheter insertion systems by Flexicath

Aug 31, 2012

Catheter insertion devices maker Flexicath wins FDA clearance for its newest M/29 Midterm series. The FDA awarded 510(k) clearance to Flexicath for its pressure injectable M/29 Midterm catheters, the company announced last week. The Pittsburgh-based catheter insertion systems maker aims to address "blood stream infection control issues" with its devices, according to a press release. News Well, 510(k), Catheters, Regulatory/Complianceread more

Flexicath Frequently Asked Questions (FAQ)

  • What is Flexicath's latest funding round?

    Flexicath's latest funding round is Unattributed VC.

  • How much did Flexicath raise?

    Flexicath raised a total of $2.2M.

  • Who are the investors of Flexicath?

    Investors of Flexicath include Zitelman Group, The Trendlines Group and Pittsburgh Life Sciences Greenhouse.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.